157 related articles for article (PubMed ID: 3107116)
1. A sensitive ELISA for von Willebrand factor (vWf:Ag).
Ingerslev J
Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116
[TBL] [Abstract][Full Text] [Related]
2. [Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].
Mazurier C; Parquet-Gernez A; Goudemand M
Pathol Biol (Paris); 1977 Dec; 25 Suppl():18-24. PubMed ID: 353655
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
[TBL] [Abstract][Full Text] [Related]
6. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
7. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
Zimmerman TS; Voss R; Edgington TS
J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
[TBL] [Abstract][Full Text] [Related]
9. Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.
Hall JD; Willis DW; Evatt BL; Jackson DW
Thromb Haemost; 1987 Jun; 57(3):332-6. PubMed ID: 3116703
[TBL] [Abstract][Full Text] [Related]
10. A sensitive immunoassay for von Willebrand factor.
Benson RE; Catalfamo JL; Brooks M; Dodds WJ
J Immunoassay; 1991; 12(3):371-90. PubMed ID: 1939665
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
Neugebauer BM; Goy C; Budek I; Seitz R
Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
[TBL] [Abstract][Full Text] [Related]
12. Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers.
Brooks M; Raymond S; Catalfamo J
J Am Vet Med Assoc; 1996 Sep; 209(5):930-3. PubMed ID: 8790543
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease--results based on an epidemiological investigation.
Rodeghiero F; Castaman G; Tosetto A
Thromb Haemost; 1990 Nov; 64(3):349-52. PubMed ID: 2096485
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
Soff GA; Green D
J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
[TBL] [Abstract][Full Text] [Related]
16. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
[TBL] [Abstract][Full Text] [Related]
17. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
18. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
Heath AB; Barrowcliffe TW
Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
20. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
